I-Mab Announces Participation at Jefferies and Piper Conferences in November
- Written by PR Newswire
![]() |
ROCKVILLE, Md. and SHANGHAI, China, Nov. 6, 2023 /PRNewswire/ -- I-Mab (Nasdaq: IMAB) (the "Company"), a global biotechnology company focused on bringing highly differentiated medicines to patients around the world through the discovery, development, and commercialization of novel immunotherapies and biologics, today announced its in-person...
Read more: I-Mab Announces Participation at Jefferies and Piper Conferences in November















